- Home
- TOPS vs ENLV Comparison
TOPS vs ENLV Comparison
Compare TOPS & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TOPS | ENLV |
|---|---|---|
| Founded | 2000 | 2005 |
| Country | Greece | Israel |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.1M | 26.6M |
| IPO Year | 2004 | 1995 |
Fundamental Metrics
Financial Performance| Metric | TOPS | ENLV |
|---|---|---|
| Price | $5.60 | $0.87 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 18.0K | ★ 11.5M |
| Earning Date | 03-19-2026 | 11-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 2.30 | N/A |
| Revenue | ★ $87,872,000.00 | N/A |
| Revenue This Year | $9.90 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $2.47 | ★ N/A |
| Revenue Growth | ★ 4.77 | N/A |
| 52 Week Low | $5.00 | $0.83 |
| 52 Week High | $11.47 | $2.10 |
Technical Indicators
Market Signals| Indicator | TOPS | ENLV |
|---|---|---|
| Relative Strength Index (RSI) | 32.62 | 39.09 |
| Support Level | $5.90 | $0.89 |
| Resistance Level | $6.05 | $1.25 |
| Average True Range (ATR) | 0.24 | 0.11 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 21.28 | 4.23 |
Price Performance
Historical ComparisonAbout TOPS TOP Ships Inc.
TOP Ships Inc owns tanker vessels throughout the world. The Company is an international owner and operator of modern, fuel-efficient eco tanker vessels focusing on the transportation of crude oil, petroleum products (clean and dirty), and bulk liquid chemicals. It generates revenue from the Time Charter agreements.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.